Home » Topics » BioWorld Science

BioWorld Science
RSS

Data analysis completed for second cohort in part I of phase I/IIa study of CRV-431

Aug. 8, 2018

Korean researchers divulge new antiviral compounds

Aug. 8, 2018

Resverlogix announces seventh positive recommendation for phase III study of apabetalone

Aug. 8, 2018

Salvensis patents compounds for schistosomiasis

Aug. 8, 2018

First patients dosed in phase I/II study of FX-322

Aug. 8, 2018

Suppressive role of exosomal TRIM3 in gastric cancer growth: potential biomarker and therapy target

Aug. 8, 2018

Multigene assay constructed to predict late recurrence in ER-positive breast cancer

Aug. 8, 2018

Blood protein networks linked to complex diseases

Aug. 8, 2018

NanoViricides' topical dermal shingles drug candidates show efficacy in rat model

Aug. 7, 2018

Novel long-range PCR method allows Ebola virus genome sequencing from ecological or clinical samples

Aug. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...